| Cardiomyopathy |
1 |
1 |
| Cerebrovascular Accident |
0 |
0.95 |
| Thromboembolism |
0 |
0.9 |
| Atrial Fibrillation |
0 |
0.77 |
| Anticoagulation Therapy |
0 |
0.69 |
| Hypertension |
0 |
0.64 |
| Aspirin |
0 |
0.55 |
| Recurrent Stroke |
0 |
0.28 |
| Biomarker |
0 |
0.21 |
| Hemorrhage |
0 |
0.21 |
| Intracranial Hemorrhage |
0 |
0.19 |
| B-Type Natriuretic Peptide |
0 |
0.15 |
| Coronary Artery Disease (CAD) |
0 |
0.15 |
| Heart Failure (HF) |
0 |
0.15 |
| Brain |
0 |
0.14 |
| Heart |
0 |
0.14 |
| Hemorrhagic Stroke |
0 |
0.14 |
| New York |
0 |
0.14 |
| Antithrombotics |
0 |
0.12 |
| Blood |
0 |
0.07 |
| Canada |
0 |
0.07 |
| Dementia |
0 |
0.07 |
| Disability |
0 |
0.07 |
| Embolic Stroke |
0 |
0.07 |
| Embolism |
0 |
0.07 |
| Epidemiology |
0 |
0.07 |
| Europe |
0 |
0.07 |
| Fellowship |
0 |
0.07 |
| Hospital |
0 |
0.07 |
| Ischemic Stroke |
0 |
0.07 |
| Myocardial Infarction (MI) |
0 |
0.07 |
| Traumatic Brain Injury |
0 |
0.06 |